Article
A Nimbolide-Based Kinase Degrader Preferentially Degrades Oncogenic BCR-ABL
medRxiv · 2020 · Tong, B.; Spradlin, J. N.; Novaes, L. F. T.; Zhang, E.; Hu, X.; Moeller, M.; Brittain, S. M.; McGregor, L. M.; McKenna, J. M.; Tallarico, J. A.; Schirle, M.; Maimone, T. J.; Nomura, D. K.
Key facts
| Title | A Nimbolide-Based Kinase Degrader Preferentially Degrades Oncogenic BCR-ABL |
|---|---|
| First author | Tong, B.; Spradlin, J. N.; Novaes, L. F. T.; Zhang, E.; Hu, X.; Moeller, M.; Brittain, S. M.; McGregor, L. M.; McKenna, J. M.; Tallarico, J. A.; Schirle, M.; Maimone, T. J.; Nomura, D. K. |
| Journal | medRxiv |
| Published | Apr 3, 2020 |
| DOI | 10.1101/2020.04.02.022541 |
| Devices mentioned | 022541 |
At a glance
- 1–9 FDA submissions mentioned
- None Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1